US 8846908
Tricyclic carbamate JAK inhibitors
granted A61KA61K31/423A61K31/506
Quick answer
US patent 8846908 (Tricyclic carbamate JAK inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/423, A61K31/506, A61K31/538, A61K31/5383